Electrolyte imbalances nursing mnemonics: sodium, potassium, calcium, and magnesium

LS
By Lindsay Smith, AGPCNP
Updated October 15, 2026

Reviewed for clinical accuracy · Methodology: NIH, NCBI, AANP guidelines

Electrolyte imbalances are one of the most heavily tested topics in nursing school and on the NCLEX. Knowing what each electrolyte does is the easy half. The demanding half is rapid recall – naming which imbalance produces which cluster of symptoms, under exam pressure or at the bedside with a patient in front of you.

That is where mnemonics become essential. Rather than memorizing eight separate lists of symptoms, you can anchor each imbalance to a short acronym and let the pattern do the work. This article covers the four most clinically critical electrolytes – sodium, potassium, calcium, and magnesium – with proven mnemonics for both the high and low states of each. Master these eight mnemonics and you have covered the core of NCLEX electrolyte content.

The master pattern: high means excited, low means flat

Before jumping into the individual mnemonics, there is one overarching principle that ties everything together:

Elevated electrolyte levels → depressed or flaccid neuromuscular function Depleted electrolyte levels → hyperexcitable or irritable neuromuscular function

This pattern holds best for calcium and magnesium. Low calcium and low magnesium produce hyperexcitability – muscle cramping, tetany, increased reflexes, arrhythmias. High calcium and high magnesium produce depression – muscle weakness, flaccidity, decreased reflexes, slowed conduction. Potassium is the exception at skeletal muscle: both low and high potassium cause weakness, while both put the heart at risk of arrhythmia. Sodium follows its own rules around fluid shifts and neurological symptoms.

Keep this principle in mind as you work through each mnemonic. It will help you reconstruct the correct symptoms even if you cannot remember every letter.


Sodium (Na⁺): SALT LOSS and FRIED SALT

Normal serum sodium: 135–145 mEq/L

Sodium is the primary extracellular cation and the main driver of osmolarity. Changes in sodium level affect how water moves between compartments – and because the brain is enclosed in a fixed-volume skull, sodium imbalances produce predominantly neurological symptoms.

Hyponatremia – SALT LOSS

Serum sodium below 135 mEq/L.

S – Stupor / confusion A – Anorexia L – Lethargy T – Tendon reflexes decreased L – Limp muscles O – Orthostatic hypotension S – Seizures (in severe cases) S – Stomach cramps / nausea

When sodium falls, water shifts into cells, including neurons. The result is cellular swelling and neurological dysfunction. Patients become progressively confused and lethargic, then may develop seizures if sodium drops sharply or falls below about 120 mEq/L. Muscles become weak and hypotonic. Orthostatic hypotension occurs as vascular volume is compromised in hypovolemic presentations.

The word SALT LOSS is itself the cue – the patient is losing salt, so recall the mnemonic by its meaning, not just its letters.

Critical nursing note: Sodium correction must be gradual. Rapid correction of chronic hyponatremia risks osmotic demyelination syndrome (ODS), a devastating neurological complication. The 2013 US expert panel sets a ceiling of 10–12 mEq/L rise in 24 hours for most patients, tightening to no more than 8 mEq/L in patients at high ODS risk – serum sodium of 105 mEq/L or lower, alcohol use disorder, malnutrition, advanced liver disease, or hypokalemia. The 2014 European guideline limits the rise to 10 mEq/L in the first 24 hours and 8 mEq/L in each 24 hours after that. Worth knowing at the bedside: ODS has been documented even in patients corrected within these limits, so slower is safer in the high-risk group. Always follow your facility protocol and physician orders closely.

Hypernatremia – FRIED SALT

Serum sodium above 145 mEq/L.

F – Flushed skin R – Restlessness / agitation I – Increased blood pressure E – Edema (in hypervolemic states) D – Decreased urine output S – Skin dry / dry mucous membranes A – Agitation L – Low-grade fever T – Thirst (intense)

When sodium rises, water shifts out of cells. The brain shrinks slightly, producing neurological irritability – restlessness, agitation, and in severe cases, altered consciousness. The intense thirst is the body’s attempt to restore balance. Skin and mucous membranes are dry because the body is relatively water-depleted.

The mnemonic FRIED SALT is easy to picture: imagine fried, salty food. Eating too much of it makes you thirsty, flushed, and restless – exactly the clinical picture of hypernatremia.


Potassium (K⁺): A SIC WALT and MURDER

Normal serum potassium: 3.5–5.0 mEq/L

Potassium is the primary intracellular cation and the key electrolyte governing cardiac and neuromuscular function. Even small deviations outside the normal range can produce life-threatening arrhythmias. A helpful anchor: K is for cardiac. Whenever potassium is out of range, the heart is at risk.

Hypokalemia – A SIC WALT

Serum potassium below 3.5 mEq/L.

A – Alkalosis (metabolic) S – Shallow respirations I – Irritability C – Confusion / drowsiness W – Weakness / fatigue A – Arrhythmias (tachycardia, ventricular ectopy) L – Lethargy T – Thready pulse

Low extracellular potassium makes the resting membrane potential of muscle cells more negative (hyperpolarized), so they are harder to excite. Muscle cells become weak – this includes skeletal, smooth, and cardiac muscle. Respiratory muscles can weaken enough in severe hypokalemia to cause respiratory compromise, which is why shallow respirations appear in the mnemonic. Gastrointestinal smooth muscle becomes hypoactive, producing constipation and ileus.

On the ECG, hypokalemia produces characteristic changes: flattened or inverted T waves, prominent U waves (a small positive deflection after the T wave in the precordial leads), and a prolonged QT interval. These changes indicate increased risk of ventricular arrhythmias. Clinical symptoms typically appear when serum potassium falls below 3.0 mEq/L.

Metabolic alkalosis co-occurs with hypokalemia for a physiological reason: as potassium shifts out of cells to compensate for low extracellular levels, hydrogen ions shift in – raising the blood pH. This is why A SIC WALT begins with Alkalosis.

Critical nursing note: IV potassium must never be given by IV push. It must be diluted and infused slowly via a monitored line. Rapid infusion causes cardiac arrest. Always verify concentration limits and monitor the patient on continuous telemetry during potassium replacement.

Hyperkalemia – MURDER

Serum potassium above 5.0 mEq/L.

M – Muscle weakness U – Urine (oliguria or anuria) R – Respiratory distress D – Decreased cardiac contractility E – ECG changes R – Reflexes decreased or absent

Hyperkalemia produces the opposite of hypokalemia: instead of underexcitability, cells initially become hyperexcitable – but then become inexcitable as potassium continues to rise and the membrane potential is persistently altered.

The ECG changes in hyperkalemia are one of the most important clinical findings nurses must recognize. The classic teaching order as potassium rises is:

  1. Tall, peaked T waves – usually described as the earliest change
  2. Prolonged PR interval and flattened P waves
  3. Widened QRS complex – indicates worsening conduction delay
  4. Sine wave pattern – a late, pre-terminal finding
  5. Ventricular fibrillation or asystole – without treatment

Real patients do not reliably follow this order. The studies UKKA reviews found peaked T waves in only about 30–36% of patients with hyperkalemia, and a patient can move from peaked T waves to ventricular fibrillation or asystole quickly. A normal ECG does not rule out dangerous hyperkalemia.

The clinical symptoms include generalized muscle weakness (the MURDER M), paresthesias, nausea, and malaise. Decreased cardiac contractility and arrhythmias develop as levels climb. Decreased deep tendon reflexes reflect the depression of neuromuscular excitability at high potassium levels.

Renal causes dominate – the kidney is the primary route for potassium excretion, so acute kidney injury or chronic kidney disease are common precipitants.

Treatment hierarchy: IV calcium stabilizes the cardiac membrane and is given first when hyperkalemic ECG changes are present. It does not lower the potassium level; it protects the myocardium while other agents work. The UK Kidney Association (UKKA) guideline, updated July 2026, gives 30 mL of 10% calcium gluconate over 10 minutes and does not recommend calcium when the ECG is normal. US orders are often 1–3 g, and the US label caps a bolus at 200 mg per minute, so never push it faster than 5 minutes per gram.

Insulin with glucose (10 units with 25 g) remains the most effective emergency shifting therapy. Per UKKA, potassium starts to fall within 15 minutes, the peak fall of about 0.65–1.0 mmol/L comes at 30–60 minutes, and the effect lasts up to about 2 hours before potassium rebounds. Hypoglycemia is the main hazard, so UKKA uses a two-stage approach: if the pre-treatment glucose is below 7.0 mmol/L (about 126 mg/dL), a 10% glucose infusion at 50 mL/h for 5 hours follows the insulin-glucose dose, and glucose is checked regularly for 6 hours. Nebulized albuterol (salbutamol) 10–20 mg is an adjunct only, because up to 40% of patients with end-stage kidney disease do not respond to it.

A point students are frequently taught wrongly: sodium bicarbonate is no longer part of routine acute hyperkalemia management. UKKA suggests against routine IV bicarbonate for acute hyperkalemia; the evidence that it lowers potassium acutely is weak, and it adds a sodium and fluid load. Sodium polystyrene sulfonate (Kayexalate) is a poor emergency drug. Its US label warns that it may be insufficient for rapid correction of severe hyperkalemia and that intestinal necrosis, which may be fatal, has been reported, and UKKA no longer recommends resin binders for acute hyperkalemia. The newer binders lower total body potassium: sodium zirconium cyclosilicate (Lokelma) starts working in about 1 hour, and patiromer (Veltassa) in about 7 hours. Both US labels state they should not be used as emergency treatment for life-threatening hyperkalemia because of delayed onset, although UKKA gives sodium zirconium cyclosilicate alongside standard emergency treatment in severe hyperkalemia. Dialysis is the definitive therapy in refractory hyperkalemia or established kidney failure. For full dosing detail, see the hyperkalemia nursing guide.


Calcium (Ca²⁺): CATS and BACK ME

Normal serum calcium: 8.5–10.5 mg/dL

Calcium plays a central role in neuromuscular transmission, cardiac conduction, hormone secretion, and bone metabolism. In clinical settings, ionized (free) calcium is the form that matters physiologically. About 45% of total serum calcium is bound to plasma proteins, mainly albumin, and roughly 40% is ionized, so always interpret calcium levels in the context of albumin. A low albumin will lower the total serum calcium reading as a lab artifact, without indicating true hypocalcemia.

Hypocalcemia – CATS

Serum calcium below 8.5 mg/dL.

C – Convulsions A – Arrhythmias T – Tetany S – Spasms / Stridor

Low calcium increases neuromuscular excitability – the threshold potential for neurons drops, and they fire more easily. The result is spontaneous muscle spasms, tetany, and, in severe cases, seizures. Laryngospasm can produce stridor and represents a life-threatening emergency. Cardiac arrhythmias occur due to prolonged QT intervals on ECG.

Two classic bedside signs help you detect hypocalcemia:

Chvostek’s sign: Tap the cheek about 2 cm in front of the ear, over the facial nerve. A positive result is ipsilateral twitching of the facial muscles. The Chvostek sign is the weaker of the two tests. It is often absent in true hypocalcemia, and it is common in people with normal calcium: a neurology team found it in 6 of 11 young healthy colleagues, and in a US population sample of 3,434 adults a positive sign went with normal-to-high calcium rather than low calcium. Treat a positive Chvostek as a prompt to check a calcium level, never as confirmation of hypocalcemia on its own.

Trousseau’s sign: Inflate a blood pressure cuff to 20 mmHg above systolic pressure and hold for 2–3 minutes. A positive result is carpopedal spasm – the wrist flexes and the fingers extend, resembling a hand position described as “main d’accoucheur” (hand of the obstetrician). The Trousseau sign outperforms Chvostek’s on both sensitivity and specificity, reported at 94% and 99% respectively, with false positives in only about 1–4% of normocalcemic individuals. This is the bedside test to rely on when you suspect latent tetany.

A helpful teaching phrase: “Low calcium can’t relax.” Low calcium causes uncontrolled contraction – exactly what CATS represents.

Hypercalcemia – BACK ME

Serum calcium above 10.5 mg/dL.

B – Bone pain A – Arrhythmias C – Cardiac arrest (in severe cases) K – Kidney stones M – Muscle weakness E – Excessive urination (polyuria)

High calcium depresses neuromuscular excitability – the opposite of hypocalcemia. Muscles weaken and go flaccid. The classic presentation is captured in the clinical phrase “bones, groans, stones, and moans” (bone pain, GI discomfort, kidney stones, and neuropsychiatric symptoms). BACK ME covers the most NCLEX-relevant manifestations.

Hypercalcemia is most commonly caused by hyperparathyroidism (in outpatients) or malignancy (in hospitalized patients). The parathyroid hormone (PTH) releases calcium from bone into the bloodstream; excessive PTH or PTH-related protein from tumors drives calcium to dangerous levels.

Kidney stones (nephrolithiasis) occur because the kidney excretes excess calcium, and calcium can precipitate in the renal collecting system. Polyuria develops as hypercalcemia impairs the kidney’s ability to concentrate urine. GI motility is reduced, producing constipation and nausea – the “groans.”

Cardiac effects include shortened QT interval and dysrhythmias. Treatment starts with IV hydration. For hypercalcemia of malignancy, the 2023 Endocrine Society guideline recommends IV hydration plus an IV bisphosphonate or denosumab, adding calcitonin when calcium is above 14 mg/dL. Loop diuretics are no longer a routine calcium-lowering therapy (the evidence for them is weak) and are kept for fluid overload once the patient is rehydrated.

Chronic calcium deficiency – whether from inadequate dietary intake, poor absorption, or vitamin D deficiency – drives secondary hyperparathyroidism, which accelerates bone resorption over time. This is one of the key mechanisms underlying osteoporosis. For a full discussion of bone density assessment, bisphosphonate pharmacology, and fracture prevention, see the osteoporosis nursing reference.


Magnesium (Mg²⁺): “Think of the reflexes”

Normal serum magnesium: 1.5–2.5 mEq/L

Magnesium is less commonly highlighted in introductory nursing courses but is clinically significant, especially in critical care and obstetrics. Magnesium regulates neuromuscular transmission, cardiac rhythm, and intracellular enzyme function. It is also closely linked to calcium and potassium metabolism – hypomagnesemia often co-occurs with and worsens both hypokalemia and hypocalcemia.

For magnesium, the master mnemonic is the deep tendon reflex (DTR):

  • Hypomagnesemia → INCREASED DTRs (hyperreflexia)
  • Hypermagnesemia → DECREASED DTRs (hyporeflexia, then absent)

This is the single most important clinical differentiator for magnesium imbalances. DTR assessment is the bedside tool nurses use to monitor patients on magnesium infusions.

Hypomagnesemia – neuromuscular excitability

Serum magnesium below 1.5 mEq/L.

Key features to remember:

  • Increased deep tendon reflexes (hyperreflexia)
  • Muscle cramps and tremors
  • Seizures in severe cases
  • Tachycardia and arrhythmias
  • Confusion and insomnia
  • Often co-presents with hypokalemia and hypocalcemia

The pattern mirrors hypocalcemia – low magnesium makes neurons fire too easily, producing spasms, tremors, and seizures. Hypomagnesemia also impairs PTH secretion and end-organ PTH response, explaining why it drives hypocalcemia. It similarly promotes renal potassium wasting, which is why correcting magnesium is often necessary before potassium replacement is effective.

A helpful phrase: “Low mag, high-strung.” Low magnesium produces a hyperexcitable, high-strung neuromuscular picture.

Common causes include chronic alcoholism, prolonged diarrhea, loop diuretic use, and inadequate dietary intake. Proton pump inhibitors (PPIs) taken long-term can also cause hypomagnesemia.

Hypermagnesemia – neuromuscular depression

Serum magnesium above 2.5 mEq/L.

Key features to remember:

  • Decreased deep tendon reflexes (hyporeflexia → absent)
  • Muscle weakness and flaccidity
  • Hypotension
  • Bradycardia
  • Decreased respirations → respiratory arrest in severe cases
  • Flushing and sedation

Hypermagnesemia is most commonly iatrogenic – occurring in patients receiving magnesium sulfate infusions, particularly in obstetrics for eclampsia prophylaxis or preterm labor management. It also occurs in patients with renal failure who cannot excrete magnesium.

Excess magnesium acts as a physiological calcium antagonist and blocks neuromuscular junctions. The result is progressive depression: reflexes disappear first, then respiratory muscles weaken, then cardiac conduction fails.

In obstetric settings, DTR monitoring is the primary safety check during mag sulfate infusions. The FDA-approved magnesium sulfate labeling gives the progression in serum concentrations:

  • 2.5–7.5 mEq/L – effective anticonvulsant range
  • above 4 mEq/L – deep tendon reflexes begin to diminish; this is the earliest detectable change, and it starts inside the therapeutic window
  • approaching 10 mEq/L – reflexes disappear entirely and respiratory paralysis becomes a hazard; heart block may occur at this level or lower
  • above 12 mEq/L – potentially fatal

That first threshold is the one students most often get wrong. Reflexes weaken while the level is still therapeutic, so a diminished knee jerk is a signal to reassess rather than an automatic stop, whereas an absent reflex means hold the infusion and notify the provider immediately. Because total serum magnesium correlates imperfectly with the ionized fraction that produces these effects, the bedside exam outranks the lab value: check patellar reflexes, respiratory rate, and urine output before each dose. IV calcium is the antidote and must be at the bedside for any patient on magnesium sulfate. The magnesium sulfate label lists 10–20 mL of a 5% calcium solution; many obstetric protocols use 1 g (10 mL of 10%) calcium gluconate. Whatever the ordered dose, the calcium gluconate label caps a bolus at 200 mg per minute in adults, so each 1 g takes at least 5 minutes. Ventilatory support comes first if the patient has stopped breathing.

A helpful phrase: “High mag, slow drag.” Hypermagnesemia drags everything down – reflexes, respirations, heart rate, blood pressure.


Clinical context: where these mnemonics matter most

Electrolyte imbalances appear in virtually every nursing setting, but certain environments have higher concentrations:

Medical-surgical floors: Patients on diuretics (especially loop diuretics like furosemide) are at constant risk for hypokalemia, hypomagnesemia, and hypocalcemia. Patients with chronic kidney disease develop hyperkalemia and hyperphosphatemia (which drives hypocalcemia).

Critical care units: Critically ill patients often have multiple concurrent electrolyte derangements due to fluid resuscitation, renal dysfunction, and aggressive diuresis. ECG monitoring is continuous, and nurses must recognize the characteristic changes for potassium and calcium.

Oncology: Hypercalcemia of malignancy is one of the most common life-threatening metabolic complications of cancer. Tumor lysis syndrome drives hyperkalemia, hyperphosphatemia, and hypocalcemia simultaneously – a cluster that requires urgent management.

Labor and delivery: Magnesium sulfate infusions for eclampsia and preterm labor make hypermagnesemia a routine clinical concern. DTR checks, respiratory rate monitoring, and urine output assessment are core nursing responsibilities during every mag infusion.

Post-surgical: Patients who have had thyroid or parathyroid surgery are at high risk for hypocalcemia due to incidental parathyroid damage or removal. Nurses in surgical recovery watch closely for the early signs – tingling around the mouth, positive Chvostek’s sign, and muscle cramping.


Common mistakes to avoid

Confusing DTR direction for magnesium vs calcium. Low calcium and low magnesium both cause hyperreflexia, while high magnesium causes hyporeflexia, and an absent reflex during a magnesium infusion calls for immediate intervention. Keep the reflex direction tied to magnesium specifically, since mag infusions create a clinical scenario where DTR monitoring is a routine, active nursing responsibility.

Misattributing U waves. U waves on ECG are not always pathological, but a prominent U wave in the setting of muscle weakness and fatigue should prompt a potassium check. Students sometimes confuse U waves with T waves on a fast rhythm strip.

Forgetting albumin when interpreting calcium. A serum calcium of 7.8 mg/dL in a patient with albumin of 2.0 g/dL may reflect normal ionized calcium. Always request an ionized calcium or use the correction formula: corrected calcium = measured calcium + 0.8 × (4.0 − patient albumin).

Treating sodium too quickly. Both hyponatremia and hypernatremia require gradual correction. The osmotic demyelination risk with rapid hyponatremia correction is a high-yield NCLEX topic – the answer to “what is the risk of correcting hyponatremia too rapidly?” is osmotic demyelination syndrome, not simply “cerebral edema.”

Forgetting that potassium and magnesium are linked. Hypokalemia that does not respond to potassium replacement often indicates concurrent hypomagnesemia. The kidney cannot retain potassium effectively when magnesium is depleted. Replace magnesium first, or concurrently.


Electrolyte knowledge connects directly to other clinical skills:

  • Chvostek sign – detailed guide to performing and interpreting this bedside hypocalcemia test
  • Trousseau sign – the more specific bedside sign for hypocalcemia; understand both before your clinical rotation
  • MONA mnemonic – cardiac emergencies often involve ECG changes that overlap with potassium and calcium imbalances; knowing MONA helps you see the full picture
  • OLDCARTS mnemonic – structured symptom assessment that helps you elicit the relevant history when a patient presents with weakness, cramping, or other electrolyte symptoms
  • Osteoporosis nursing reference – calcium’s long-term role in bone metabolism; full coverage of DEXA scoring, bisphosphonate therapy, fall prevention, and NCLEX practice questions

Summary

Eight mnemonics cover the core of electrolyte imbalance nursing:

ElectrolyteLow stateMnemonicHigh stateMnemonic
SodiumHyponatremiaSALT LOSSHypernatremiaFRIED SALT
PotassiumHypokalemiaA SIC WALTHyperkalemiaMURDER
CalciumHypocalcemiaCATSHypercalcemiaBACK ME
MagnesiumHypomagnesemiaLow = high-strung (↑DTRs)HypermagnesemiaHigh = slow drag (↓DTRs)

The underlying pattern ties them together: low electrolyte levels generally produce hyperexcitability and high levels generally produce depression – with the heart at risk at both extremes of potassium, and the deep tendon reflex serving as your clinical compass for magnesium.

These mnemonics are tools to get you started, but your goal in nursing practice is to understand the physiology well enough that you could reconstruct the symptom picture from first principles. The mnemonic helps you recall quickly; the pathophysiology helps you act correctly.


This article is for educational purposes and reflects current clinical guidelines as of 2026. Always follow your facility’s protocols and the most current guidelines in clinical practice.


More cheat sheets and study guides

Browse the full nursing cheat sheet library for lab values, EKG interpretation, clinical assessment guides, and printable PDFs.

References

[1] Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581–1589. doi:10.1056/NEJM200005253422107

[2] Sterns RH. Disorders of plasma sodium – causes, consequences, and correction. N Engl J Med. 2015;372(1):55–65. doi:10.1056/NEJMra1404489

[3] Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493–1499. doi:10.1056/NEJM200005183422006

[4] Mount DB. Disorders of potassium balance. In: Taal MW, Chertow GM, Marsden PA, et al, eds. Brenner and Rector’s The Kidney. 9th ed. Philadelphia: Saunders; 2012:640–688.

[5] Weiner ID, Wingo CS. Hyperkalemia: a potential silent killer. J Am Soc Nephrol. 1998;9(8):1535–1543.

[6] Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis: core curriculum 2019. Am J Kidney Dis. 2019;74(5):682–695. doi:10.1053/j.ajkd.2019.03.427

[7] Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–3569. doi:10.1210/jc.2014-1413

[8] Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10(7):1616–1622.

[9] Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med. 2006;355(17):1834–1836. doi:10.1056/NEJMc066308

[10] Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005;62(16):1663–1682. doi:10.2146/ajhp040300

[11] Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder. Kidney Int Suppl. 2017;7(1):1–59. doi:10.1016/j.kisu.2017.04.001

[12] Wacker WE, Parisi AF. Magnesium metabolism. N Engl J Med. 1968;278(12):658–663. doi:10.1056/NEJM196803212781205

[13] Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. BMJ. 1973;4(5893):643–646. doi:10.1136/bmj.4.5893.643

[14] Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29(3):282–299. doi:10.1016/j.semnephrol.2009.03.002

[15] Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract. 2012;14(2):1–17.

[16] Alfonzo A, Harrison A, Baines R, Chu A, Mann S, MacRury M. Clinical practice guideline: management of hyperkalaemia in adults. UK Kidney Association; updated July 2026. https://www.ukkidney.org/sites/default/files/documents/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20UPDATED%20JULY%202026_0.pdf

[17] Patel M, McMahon K, Hu EW. Trousseau sign. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK557832/

[18] Magnesium sulfate injection, USP – prescribing information. US Food and Drug Administration / DailyMed. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=6a5d362b-7aa7-40d3-898d-09407cce0713&type=display

[19] Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1–S42. doi:10.1016/j.amjmed.2013.07.006

[20] Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1–G47. doi:10.1530/EJE-13-1020

[21] El-Hajj Fuleihan G, Clines GA, Hu MI, et al. Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2023;108(3):507–528. doi:10.1210/clinem/dgac621

[22] LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008;149(4):259–263. doi:10.7326/0003-4819-149-4-200808190-00007

[23] Hujoel IA. The association between serum calcium levels and Chvostek sign: a population-based study. Neurol Clin Pract. 2016;6(4):321–328. doi:10.1212/CPJ.0000000000000270

[24] Méneret A, Guey S, Degos B. Chvostek sign, frequently found in healthy subjects, is not a useful clinical sign. Neurology. 2013;80(11):1067. doi:10.1212/WNL.0b013e31828728bc

[25] US prescribing information (DailyMed), accessed October 2026: calcium gluconate injection (bolus rate not to exceed 200 mg/min in adults), Lokelma (sodium zirconium cyclosilicate), Veltassa (patiromer), and sodium polystyrene sulfonate suspension. https://dailymed.nlm.nih.gov/